Sunitinib 37.5 MG Oral Capsule — RxCUI 1541890
RxNorm drug concept · Semantic clinical drug
RxCUI 1541890
Semantic clinical drug · SCD
● Current RxNorm concept 36 FDA products
48 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1541890
Official nameSunitinib 37.5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assunitinib (as sunitinib malate) 37.5 MG Oral Capsule; SUNItinib malate 37.5 MG Oral Capsule
FDA products mapped36
Package NDCs mapped48
Reported Medicaid activity (SDUD)39 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sunitinib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's actually quite different from traditional chemotherapy. Sunitinib is what we call a targeted therapy — it blocks specific proteins on cancer cells that tell them to grow and b...
- What exactly does sunitinib do — is it like regular chemotherapy?
- That's a great question. The 4-weeks-on, 2-weeks-off schedule — called Schedule 4/2 — is used for GIST and kidney cancer to give your body a chance to recover from side effects bef...
- I noticed I take it for 4 weeks and then stop for 2 weeks. Why the break?
🕸️ Concept Web — How Sunitinib 37.5 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sunitinib 37.5 MG Oral Capsule
RxCUI 1541890 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sunitinib
357977IN
-
Sunitinib
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Sutent
616274BN
-
Sutent
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sunitinib Oral Capsule
616278SCDF -
Sunitinib Oral Product
1160852SCDG -
Sunitinib Pill
1160853SCDG -
Sunitinib Oral Capsule [Sutent]
616282SBDF -
Sutent Oral Product
1185474SBDG -
Sutent Pill
1185475SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Sunitinib Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sunitinib 37.5 MG
1541889SCDC -
Sunitinib 37.5 MG Oral Capsule [Sutent]
1541928SBD -
Sunitinib 37.5 MG [Sutent]
1541927SBDC
-
Sunitinib 37.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sunitinib 37.5 MG
SCDC · 1541889 -
Sunitinib Oral Capsule
SCDF · 616278 -
Sunitinib Oral Product
SCDG · 1160852 -
Sunitinib Pill
SCDG · 1160853
Brand-Name Concepts
-
Sunitinib 37.5 MG Oral Capsule [Sutent]
SBD · 1541928 -
Sunitinib 37.5 MG [Sutent]
SBDC · 1541927 -
Sunitinib Oral Capsule [Sutent]
SBDF · 616282 -
Sutent Oral Product
SBDG · 1185474 -
Sutent Pill
SBDG · 1185475 -
Sutent
BN · 616274
📦 FDA Products & Package NDCs
36 products · 48 package NDCs
48 package NDCs map to RxCUI 1541890 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00069-0550-38 | 28 CAPSULE in 1 BOTTLE (0069-0550-38) | SUTENT | Pfizer Laboratories Div Pfizer Inc | 2006-01-26 |
| 00069-0770-38 | 28 CAPSULE in 1 BOTTLE (0069-0770-38) | SUTENT | Pfizer Laboratories Div Pfizer Inc | 2006-01-26 |
| 00069-0830-38 | 28 CAPSULE in 1 BOTTLE (0069-0830-38) | SUTENT | Pfizer Laboratories Div Pfizer Inc | 2014-07-12 |
| 00069-0980-38 | 28 CAPSULE in 1 BOTTLE (0069-0980-38) | SUTENT | Pfizer Laboratories Div Pfizer Inc | 2006-01-26 |
| 00093-8199-28 | 28 CAPSULE in 1 BOTTLE (0093-8199-28) | Sunitinib Malate | Teva Pharmaceuticals USA, Inc. | 2021-12-22 |
| 00093-8224-28 | 28 CAPSULE in 1 BOTTLE (0093-8224-28) | Sunitinib Malate | Teva Pharmaceuticals USA, Inc. | 2021-12-22 |
| 00093-8229-28 | 28 CAPSULE in 1 BOTTLE (0093-8229-28) | Sunitinib Malate | Teva Pharmaceuticals USA, Inc. | 2021-12-22 |
| 00093-8231-28 | 28 CAPSULE in 1 BOTTLE (0093-8231-28) | Sunitinib Malate | Teva Pharmaceuticals USA, Inc. | 2021-12-22 |
| 00378-6678-28 | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6678-28) | Sunitinib Malate | Mylan Pharmaceuticals Inc. | 2022-01-04 |
| 00378-6679-28 | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6679-28) | Sunitinib Malate | Mylan Pharmaceuticals Inc. | 2022-01-04 |
| 00378-6680-28 | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6680-28) | Sunitinib Malate | Mylan Pharmaceuticals Inc. | 2022-01-04 |
| 00378-6681-28 | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6681-28) | Sunitinib Malate | Mylan Pharmaceuticals Inc. | 2022-01-04 |
| 42291-0901-28 | 28 CAPSULE in 1 BOTTLE (42291-901-28) | Sunitinib Malate | AvKARE | 2023-10-11 |
| 42291-0902-28 | 28 CAPSULE in 1 BOTTLE (42291-902-28) | Sunitinib Malate | AvKARE | 2023-10-11 |
| 42291-0903-28 | 28 CAPSULE in 1 BOTTLE (42291-903-28) | Sunitinib Malate | AvKARE | 2023-10-11 |
| 42291-0904-28 | 28 CAPSULE in 1 BOTTLE (42291-904-28) | Sunitinib Malate | AvKARE | 2023-10-11 |
| 43598-0045-28 | 4 BLISTER PACK in 1 CARTON (43598-045-28) / 7 CAPSULE in 1... | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0045-63 | 28 CAPSULE in 1 BOTTLE (43598-045-63) | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0046-28 | 4 BLISTER PACK in 1 CARTON (43598-046-28) / 7 CAPSULE in 1... | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0046-63 | 28 CAPSULE in 1 BOTTLE (43598-046-63) | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0047-28 | 4 BLISTER PACK in 1 CARTON (43598-047-28) / 7 CAPSULE in 1... | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0047-63 | 28 CAPSULE in 1 BOTTLE (43598-047-63) | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0048-28 | 4 BLISTER PACK in 1 CARTON (43598-048-28) / 7 CAPSULE in 1... | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 43598-0048-63 | 28 CAPSULE in 1 BOTTLE (43598-048-63) | SUNITINIB MALATE | Dr.Reddys Laboratories Inc | 2022-11-30 |
| 59651-0464-28 | 28 CAPSULE in 1 BOTTLE (59651-464-28) | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0464-29 | 4 BLISTER PACK in 1 CARTON (59651-464-29) / 7 CAPSULE in 1... | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0465-28 | 28 CAPSULE in 1 BOTTLE (59651-465-28) | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0465-29 | 4 BLISTER PACK in 1 CARTON (59651-465-29) / 7 CAPSULE in 1... | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0466-28 | 28 CAPSULE in 1 BOTTLE (59651-466-28) | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0466-29 | 4 BLISTER PACK in 1 CARTON (59651-466-29) / 7 CAPSULE in 1... | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0467-28 | 28 CAPSULE in 1 BOTTLE (59651-467-28) | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 59651-0467-29 | 4 BLISTER PACK in 1 CARTON (59651-467-29) / 7 CAPSULE in 1... | SUNITINIB MALATE | Aurobindo Pharma Limited | 2024-03-14 |
| 63304-0091-27 | 28 CAPSULE in 1 BOTTLE (63304-091-27) | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0091-86 | 4 BLISTER PACK in 1 BOX (63304-091-86) / 7 CAPSULE in 1 BLI... | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0092-27 | 28 CAPSULE in 1 BOTTLE (63304-092-27) | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0092-86 | 4 BLISTER PACK in 1 BOX (63304-092-86) / 7 CAPSULE in 1 BLI... | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0093-27 | 28 CAPSULE in 1 BOTTLE (63304-093-27) | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0093-86 | 4 BLISTER PACK in 1 BOX (63304-093-86) / 7 CAPSULE in 1 BLI... | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0094-27 | 28 CAPSULE in 1 BOTTLE (63304-094-27) | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 63304-0094-86 | 4 BLISTER PACK in 1 BOX (63304-094-86) / 7 CAPSULE in 1 BLI... | Sunitinib malate | Sun Pharmaceutical Industries Inc. | 2019-12-25 |
| 72205-0116-28 | 28 CAPSULE in 1 BOTTLE (72205-116-28) | Sunitinib Malate | Novadoz Pharmaceuticals LLC | 2025-06-01 |
| 72205-0117-28 | 28 CAPSULE in 1 BOTTLE (72205-117-28) | Sunitinib Malate | Novadoz Pharmaceuticals LLC | 2025-06-01 |
| 72205-0118-28 | 28 CAPSULE in 1 BOTTLE (72205-118-28) | Sunitinib Malate | Novadoz Pharmaceuticals LLC | 2025-06-01 |
| 72205-0119-28 | 28 CAPSULE in 1 BOTTLE (72205-119-28) | Sunitinib Malate | Novadoz Pharmaceuticals LLC | 2025-06-01 |
| 82293-0014-10 | 28 CAPSULE in 1 BOTTLE (82293-014-10) | Sunitinib Malate | Novugen Pharma (USA) LLC. | 2024-05-01 |
| 82293-0015-10 | 28 CAPSULE in 1 BOTTLE (82293-015-10) | Sunitinib Malate | Novugen Pharma (USA) LLC. | 2024-05-01 |
| 82293-0016-10 | 28 CAPSULE in 1 BOTTLE (82293-016-10) | Sunitinib Malate | Novugen Pharma (USA) LLC. | 2024-05-01 |
| 82293-0017-10 | 28 CAPSULE in 1 BOTTLE (82293-017-10) | Sunitinib Malate | Novugen Pharma (USA) LLC. | 2024-05-01 |
Observed labelers:
Aurobindo Pharma Limited (8) ·
Dr.Reddys Laboratories Inc (8) ·
Sun Pharmaceutical Industries Inc. (8) ·
AvKARE (4) ·
Mylan Pharmaceuticals Inc. (4) ·
Novadoz Pharmaceuticals LLC (4)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.